2025 International Congress Archives - Page 106 of 181

Medication therapy in Parkinson’s disease patients: a cross-sectional study at the University Medical Center at Ho Chi Minh City, Vietnam

T. Dang, T. Tran (HO CHI MINH, Viet Nam)
Metabolic dysfunction-associated steatotic liver disease, body mass index, and risk of Parkinson’s disease

SJ. Chung, TS. Lim, J. Jeon, JK. Kim, J. Kim, PH. Lee (Seoul, Republic of Korea)
Metabolic Imaging Correlates of Apathy in Parkinson’s Disease.

J. Arena, M. Ponce-de-Leon, L. Fiorentini, C. Obarrio, S. Vazquez, Y. Bergamo, M. Merello (Buenos Aires, Argentina)
Metabolic network signature of quantitative motor effects following deep brain stimulation in Parkinson’s disease

A. Calvano, A. Turan, U. Kleinholdermann, V. Heinecke, K. Steidel, L. Ruesing, F. Thiemig, D. Librizzi, T. Schurrat, M. Beckersjuergen, M. Luster, L. Timmermann, C. Eggers, M. Ruppert-Junck, D. Pedrosa (Marburg, Germany)
Metabolic Patterns in Multiple System Atrophy: Brain Network Insights from Spatial ICA of FDG-PET

J. Li, H. Wang, B. Wang, Z. Cen, W. Luo (Hangzhou, China)
Metabolomic breath landscape analysis unravels lipid biomarker candidates in patients with monogenic and idiopathic Parkinson’s disease

M. Malik, N. Brüggemann, T. Usnich, M. Borsche, T. Demetrowitsch, K. Schwarz, P. Bauer, K. Lohmann, C. Klein, T. Kunze (Luebeck, Germany)
Metabolomic Profiling in an Egyptian Cohort Reveals Altered Phenylalanine Metabolism and Suggests a Role for Trans-Cinnamate in Parkinson Disease

N. Shebl, S. El-Jafaary, A. Saeed, P. Elkafrawy, A. El-Sayed, S. Shamma, R. Elmer, J. Mekky, L. Mohamed, O. Kittaneh, H. El-Fawal, M. Rizig, M. Salama (Cairo, Egypt)
Metabolomics Profiling in Egyptian Patients with Alzheimer’s and Parkinson’s Diseases

S. Abdelaziz, A. Helmy, E. Hamid, M. Salama, A. Shalash (Cairo, Egypt)
Methodological considerations supporting a time-to-event primary endpoint in the PADOVA study in early-stage Parkinson’s disease participants on stable symptomatic treatment

N. Pross, G. Pagano, D. Trundell, J. Anzures-Cabrera, T. Simuni, K. Marek, N. Pavese, K. Seppi, F. Stocchi, R. Postuma, A. Monnet, L. Rutten-Jacobs, G. Respondek, L. Boak, G. Kerchner, P. Brundin, H. Svoboda, T. Nikolcheva, A. Bonni (Basel, Switzerland)
Microglial Activation and Phenotype in Air Pollution Neurotoxicity: Implications for Parkinson’s Disease

A. Tang-Tan, K. Shkirkova, A. Demetriou, S. Chen, C. Bent, L. Zhao, M. Thorwald, J. Godoy-Lugo, C. Sioutas, C. Pike, C. Finch, W. Mack (Los Angeles, USA)